Adult patients with GH deficiency have reduced lean body mass (LBM), muscle
mass, and muscle strength, suggesting an underlying abnormality of protein
metabolism. As acute GH administration has previously been reported to dec
rease protein oxidation and increase protein synthesis in GH-deficient (GHD
) adults, we investigated whether the converse might occur in untreated GH
deficiency by undertaking studies of whole body protein turnover in 10 GHD
and 13 normal subjects using a 3-h primed constant infusion of 1-[C-13]leuc
ine. Dual energy x-ray absorptiometry was used to quantify LBM and fat mass
(FM).
In normal subjects, LBM was the major, independent determinant of leucine a
ppearance (Ra; r = 0.80; P = 0.0009), leucine oxidation (r = 0.81; P = 0.00
08), and leucine incorporation into protein (r = 0.75;P = 0.003). However,
in an analysis of covariance, FM was also a significant independent determi
nant of leucine Re (P = 0.002) and leucine incorporation into protein (P =
0.003). After correcting for LBM and FM, GHD patients had significantly red
uced rates of leucine Ra (109.9 +/- 4.4 vs. 125.5 +/- 3.7 mu mol/min, respe
ctively; P = 0.02) and leucine incorporation into protein (87.0 +/- 3.9 vs.
100.3 +/- 3.3 mmol/ min; P = 0.02) compared to normal subjects. There was
no significant difference in the corrected rates of leucine oxidation betwe
en the two groups (22.9 +/- 1.3 vs. 25.2 +/- 1.0, GHD vs. normal; P = 0.20)
.
In summary, GHD adults have reduced rates of protein synthesis and protein
breakdown, but normal rates of irreversible oxidative loss; these findings
are discordant with what was predicted from the acute changes in protein me
tabolism observed with GH administration. We conclude that normalization of
protein oxidation may be a homeostatic mechanism that operates to constrai
n protein loss in GHD adults.